We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Tufts researchers devise an mRNA-based cancer vaccine delivered directly into the lymphatic system, leading to a more potent response than other cancer vaccines.
